The 2025 Myopia Research Grant will comprise of 3 awards of $500,000 each.

Cotter, OD, MS, FAAO, was recognized with the Optometrist of the Year Award by Universitat Politècnica de Catalunya Faculty of Optics and Optometry of Terrassa, and as the 2024 UAB School of Optometry’s Springer Lecturer.

Preservatives may disrupt the ocular surface, contributing to poor adherence.

Two posters presented research conducted on the optical design used in MyDay Energys and Biofinity Energys.

From eye drops to novel treatments, it’s time to assess all options for improving patients’ visual acuity.

Robins has worked in the healthcare industry for 3 decades in several high-profile corporate leadership and consulting roles.

From toxins to pollutants, the modern world contains harmful elements that impact the ocular surface.

Accommodation facility, saccadic eye movement, speed of recognition, peripheral awareness, and hand-eye coordination were all affected by a single bout of incremental maximal treadmill exercise.

DRSS results remained stable or improved with OKT-TKI, and the drug was well-tolerated in the study.

Scleral lens choice led to marked improvements of HOAs caused by radial keratotomy-induced scarring and corneal shape irregularities.

The business move aligns with EssilorLuxottica's strategy to tap into the hearing solutions space, according to the company.

Catch up on what happened in optometry during the week of January 20-January 24.

The IOLs are equipped with a non-diffractive spiral optic, which allows for a full range of vision with minimized dysphotopsia and 0% loss of transmitted light.

The updated range of lenses feature expanded negative and cylindrical powers, thinner edge thickness, and wider frame options.

Predictive software will use retinal imaging to identify patient risk for Alzheimer disease and other neurodegenerative diseases.

Ocular Services On Demand (OSOD) has operated for over 30 years in ophthalmic preclinical drug development.

The longitudinal study found that visual function and BCVA decreased with an increasing incidence rate of moderate and severe visual impairment for patients with high myopia.

The 3-year, $4.8 million award comes from the NIH Venture Program Oculomics Initiatives.

Preclinical studies evaluating NPI-001 have found that it boosts the endogenous antioxidant glutathione, which stops chemically aggressive oxygen molecules from further damaging retinal cells, according to Nacuity Pharmaceuticals.